MYC and prostate carcinoma: According to Vyas et al. (2016), sulforaphane inhibits prostate cancer stem cells by the down-regulation of the oncogenic c-Myc protein, without affecting basal glycolysis (which is promoted by c-Myc overexpression) [260].